Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • SMcTaggart
    Member
    • Jul 2010
    • 10

    #1

    Strange DE results

    Hello;

    I am using DESeq to determine which genes are differentially expressed between my treated sample and control. I am looking at three different genotypes (G1,G2,G3), each exposed to two different treatments (T1,T2), plus a control (C). For each treatment/genotype (e.g. G1T1) combination I have three replicates (G1T1R1, G1T1R2...). I am testing for differential expression between treated and control for each genotype/treatment combination.

    I am finding the results of the DE tests confusing. All of the DE genes in G1T1 are downregulated compared to controls, whereas most of the DE genes (~98%), in G2T1 are upregulated compared to controls. G3T1 in contrast, shows approximate equal numbers of up and downregulated genes. It seems possible to me that the first two patterns are a statistical artifact, and was wondering if anyone had some suggestions as to what could cause this? The volcano plots look symmetrical and the DE genes do not all lie close to the cut off curve.

    Many thanks for any ideas,

    Seanna

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 07:41 AM
0 responses
9 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Working...